Cyclerion Therapeutics, Inc.
US ˙ NasdaqCM ˙ US23255M2044

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Mark G Currie. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Mark G Currie har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:IRWD / Ironwood Pharmaceuticals, Inc. Director 613.419
US:CYCN / Cyclerion Therapeutics, Inc. President and CSO 251.648
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Mark G Currie. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CYCN / Cyclerion Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CYCN / Cyclerion Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2019-04-02 CYCN Currie Mark G 270.107 14,8100 13.505 296,2000 4.000.285 8 7384 95.720.636 2.392,85

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CYCN / Cyclerion Therapeutics, Inc. Insider Trades
Insidersalg CYCN / Cyclerion Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CYCN / Cyclerion Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2020-12-28 CYCN Currie Mark G 20.107 3,0100 1.005 60,2000 60.522 154 3.24 -57.266 -94,62
2019-12-30 CYCN Currie Mark G 25.000 2,4800 1.250 49,6000 62.000
2019-12-27 CYCN Currie Mark G 25.000 2,5500 1.250 51,0000 63.750

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CYCN / Cyclerion Therapeutics, Inc. Insider Trades
Insiderkøb IRWD / Ironwood Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CYCN / Cyclerion Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

IRWD / Ironwood Pharmaceuticals, Inc. Insider Trades
Insidersalg IRWD / Ironwood Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CYCN / Cyclerion Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2022-08-11 IRWD Currie Mark G 70.000 11,7800 70.000 11,7800 824.600 363 9.6100 -151.900 -18,42
2019-03-08 IRWD Currie Mark G 49.500 13,1500 49.500 13,1500 650.925
2019-03-07 IRWD Currie Mark G 225.500 13,2900 225.500 13,2900 2.996.895
2017-03-14 IRWD Currie Mark G 60.000 17,0600 60.000 17,0600 1.023.600

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

IRWD / Ironwood Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Mark G Currie som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-12 2025-06-10 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 45.000 613.419 7,92
2024-06-21 2024-06-18 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 24.311 568.419 4,47
2023-06-22 2023-06-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 22.350 544.108 4,28
2022-08-15 2022-08-11 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -70.000 521.758 -11,83 11,78 -824.600 6.146.309
2022-06-09 2022-06-07 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -190.383 591.758 -24,34 12,01 -2.286.500 7.107.014
2022-06-09 2022-06-07 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 190.383 782.141 32,17 11,65 2.217.962 9.111.943
2022-06-03 2022-06-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 21.571 591.758 3,78
2021-06-16 2021-06-14 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -23.571 570.187 -3,97 11,59 -273.188 6.608.467
2021-06-04 2021-06-02 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 22.766 593.758 3,99
2020-12-30 2020-12-28 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
S - Sale -20.107 251.648 -7,40 3,01 -60.522 757.460
2020-06-05 2020-06-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 21.720 570.992 3,95
2020-01-24 2020-01-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -60.000 47.707 -55,71
2020-01-24 2020-01-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -60.000 549.272 -9,85 12,59 -755.400 6.915.334
2020-01-24 2020-01-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 60.000 609.272 10,92 9,12 547.200 5.556.561
2020-01-21 2020-01-16 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -8.888 0 -100,00
2020-01-21 2020-01-16 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -8.888 549.272 -1,59 12,80 -113.766 7.030.682
2020-01-21 2020-01-16 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 8.888 558.160 1,62 10,02 89.058 5.592.763
2019-12-31 2019-12-30 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
S - Sale -25.000 271.755 -8,42 2,48 -62.000 673.952
2019-12-31 2019-12-27 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
S - Sale -25.000 296.755 -7,77 2,55 -63.750 756.725
2019-12-18 2019-12-17 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift -500 549.272 -0,09
2019-12-18 2019-12-16 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift -1.837 549.772 -0,33
2019-11-26 2019-11-22 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 75.000 75.000
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 514.698 514.698
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 140.984 140.984
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 113.413 113.413
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 50.794 50.794
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 2.500 2.500
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 27.772 27.772
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 17.490 17.490
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 37.279 37.279
2019-05-31 2019-05-29 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 22.706 551.609 4,29
2019-05-14 2019-05-10 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -4.055 528.903 -0,76 10,53 -42.699 5.569.349
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -562.500 37.500 -93,75
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -147.813 67.187 -68,75
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -109.375 140.625 -43,75
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -44.063 107.707 -29,03
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -1.771 83.229 -2,08
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -9.617 190.383 -4,81
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -8.029 101.971 -7,30
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -25.000 0 -100,00
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -41.041 0 -100,00
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -20.000 0 -100,00
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 2.995 532.958 0,57
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 1.483 529.963 0,28
2019-04-03 2019-04-02 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
P - Purchase 270.107 321.755 522,98 14,81 4.000.285 4.765.192
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 514.786 514.786
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 141.007 141.007
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 113.430 113.430
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 50.801 50.801
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 2.500 2.500
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 13.125 13.125
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 9.930 9.930
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 27.773 27.773
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 17.491 17.491
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 37.286 37.286
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 888 888
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
A - Award 51.648 51.648
2019-03-08 2019-03-08 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -49.500 528.480 -8,56 13,15 -650.925 6.949.512
2019-03-08 2019-03-07 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -225.500 577.980 -28,07 13,29 -2.996.895 7.681.354
2019-02-22 2019-02-21 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -13 803.480 0,00 14,32 -186 11.505.834
2019-02-22 2019-02-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -1.631 803.493 -0,20 14,31 -23.340 11.497.985
2019-01-31 2019-01-29 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option(Right to Buy)
A - Award 600.000 600.000
2019-01-03 2018-12-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
J - Other 20.000 20.000
2019-01-03 2018-12-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
J - Other -20.000 0 -100,00
2019-01-03 2018-12-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
J - Other 775.000 805.124 2.572,70
2019-01-03 2018-12-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
J - Other -775.000 0 -100,00
2018-10-09 2018-10-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -41.615 151.770 -21,52
2018-10-09 2018-10-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -34.480 41.041 -45,66
2018-10-09 2018-10-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -40.556 8.888 -82,02
2018-10-09 2018-10-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -116.651 30.124 -79,48 17,53 -2.044.892 528.074
2018-10-09 2018-10-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 41.615 146.775 39,57 10,24 426.138 1.502.976
2018-10-09 2018-10-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 34.480 105.160 48,78 11,11 383.073 1.168.328
2018-10-09 2018-10-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 40.556 70.680 134,63 11,25 456.255 795.150
2018-10-09 2018-10-04 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -41.615 193.385 -17,71
2018-10-09 2018-10-04 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -34.479 75.521 -31,34
2018-10-09 2018-10-04 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -40.556 49.444 -45,06
2018-10-09 2018-10-04 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -22.194 30.124 -42,42 18,75 -416.138 564.825
2018-10-09 2018-10-04 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -94.456 52.318 -64,35 17,94 -1.694.541 938.585
2018-10-09 2018-10-04 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 41.615 146.774 39,57 10,24 426.138 1.502.966
2018-10-09 2018-10-04 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 34.479 105.159 48,78 11,11 383.062 1.168.316
2018-10-09 2018-10-04 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 40.556 70.680 134,63 11,25 456.255 795.150
2018-08-28 2018-08-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -6.666 20.000 -25,00
2018-08-28 2018-08-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -41.667 0 -100,00
2018-08-28 2018-08-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -16.667 0 -100,00
2018-08-28 2018-08-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -65.000 775.000 -7,74 18,39 -1.195.350 14.252.250
2018-08-28 2018-08-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 6.666 840.000 0,80 5,48 36.530 4.603.200
2018-08-28 2018-08-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 41.667 833.334 5,26 4,89 203.752 4.075.003
2018-08-28 2018-08-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 16.667 791.667 2,15 4,89 81.502 3.871.252
2018-08-24 2018-08-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -6.667 26.666 -20,00
2018-08-24 2018-08-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -41.666 41.667 -50,00
2018-08-24 2018-08-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -16.667 16.667 -50,00
2018-08-24 2018-08-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -65.000 775.000 -7,74 18,39 -1.195.350 14.252.250
2018-08-24 2018-08-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 6.667 840.000 0,80 5,48 36.535 4.603.200
2018-08-24 2018-08-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 41.666 833.333 5,26 4,89 203.747 4.074.998
2018-08-24 2018-08-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 16.667 791.667 2,15 4,89 81.502 3.871.252
2018-08-24 2018-08-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -6.667 33.333 -16,67
2018-08-24 2018-08-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -41.667 83.333 -33,33
2018-08-24 2018-08-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -16.666 33.334 -33,33
2018-08-24 2018-08-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -65.000 775.000 -7,74 18,51 -1.203.150 14.345.250
2018-08-24 2018-08-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 6.667 840.000 0,80 5,48 36.535 4.603.200
2018-08-24 2018-08-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 41.667 833.333 5,26 4,89 203.752 4.074.998
2018-08-24 2018-08-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 16.666 791.666 2,15 4,89 81.497 3.871.247
2018-08-02 2018-07-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 12.000 30.124 66,21
2018-02-22 2018-02-21 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option(Right to Buy)
A - Award 215.000 215.000
2018-02-22 2018-02-21 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -1.634 18.124 -8,27 14,66 -23.954 265.698
2018-01-26 2018-01-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -60.000 0 -100,00
2018-01-26 2018-01-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -60.000 775.000 -7,19 15,45 -927.000 11.973.750
2018-01-26 2018-01-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 60.000 835.000 7,74 3,76 225.600 3.139.600
2017-12-11 2017-12-07 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift -1.500 19.758 -7,06
2017-03-16 2017-03-14 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -60.000 60.000 -50,00 3,76 -225.600 225.600
2017-03-16 2017-03-14 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale -60.000 775.000 -7,19 17,06 -1.023.600 13.221.500
2017-03-16 2017-03-14 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 60.000 835.000 7,74 3,76 225.600 3.139.600
2017-03-01 2017-02-27 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 250.000 250.000
2017-02-24 2017-02-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -1.800 21.258 -7,81 16,94 -30.492 360.111
2017-01-20 2017-01-18 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -55.987 0 -100,00
2017-01-20 2017-01-18 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 55.987 775.000 7,79 2,94 164.602 2.278.500
2017-01-10 2017-01-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -34.013 55.987 -37,79
2017-01-10 2017-01-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 34.013 719.013 4,97 2,94 99.998 2.113.898
2016-12-08 2016-12-07 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift -2.500 23.058 -9,78
2016-11-01 2016-10-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -300.000 0 -100,00
2016-11-01 2016-10-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 300.000 685.000 77,92 2,94 882.000 2.013.900
2016-03-11 2016-03-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -10.898 0 -100,00
2016-03-11 2016-03-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -150.000 0 -100,00
2016-03-11 2016-03-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 10.898 385.000 2,91 1,56 17.001 600.600
2016-03-11 2016-03-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -150.000 374.102 -28,62 10,86 -1.629.000 4.062.748
2016-03-11 2016-03-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 150.000 524.102 40,10 1,56 234.000 817.599
2016-03-03 2016-03-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 235.000 235.000
2016-02-26 2016-02-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -150.000 150.000 -50,00
2016-02-26 2016-02-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -150.000 374.102 -28,62 8,53 -1.279.500 3.191.090
2016-02-26 2016-02-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 150.000 524.102 40,10 1,56 234.000 817.599
2016-02-26 2016-02-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -2.154 25.558 -7,77 8,50 -18.309 217.243
2016-01-06 2016-01-04 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -64.102 10.898 -85,47
2016-01-06 2016-01-04 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 64.102 374.102 20,68 1,56 99.999 583.599
2015-03-18 2015-03-16 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 25.000 25.000
2015-03-18 2015-03-16 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 25.000 25.000
2015-03-18 2015-03-16 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 131.250 131.250
2015-03-18 2015-03-16 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
A - Award 21.875 26.098 518,00
2015-02-23 2015-02-19 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -25.000 0 -100,00
2015-02-23 2015-02-19 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -25.000 310.000 -7,46 15,67 -391.750 4.857.700
2015-02-23 2015-02-19 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 25.000 335.000 8,06 0,60 15.000 201.000
2014-11-17 2014-11-13 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20.000 25.000 -44,44
2014-11-17 2014-11-13 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -20.000 310.000 -6,06 13,63 -272.600 4.225.300
2014-11-17 2014-11-13 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 20.000 330.000 6,45 0,60 12.000 198.000
2014-05-23 2014-05-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -25.000 45.000 -35,71
2014-05-23 2014-05-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -25.000 310.000 -7,46 13,93 -348.250 4.318.300
2014-05-23 2014-05-22 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 25.000 335.000 8,06 0,60 15.000 201.000
2014-04-28 2014-04-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -25.000 70.000 -26,32
2014-04-28 2014-04-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -25.000 310.000 -7,46 11,67 -291.750 3.617.700
2014-04-28 2014-04-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 25.000 335.000 8,06 0,60 15.000 201.000
2014-03-05 2014-03-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 85.000 85.000
2014-02-20 2014-02-18 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -15.000 0 -100,00
2014-02-20 2014-02-18 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -15.000 310.000 -4,62 14,43 -216.450 4.473.300
2014-02-20 2014-02-18 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 15.000 325.000 4,84 0,60 9.000 195.000
2014-01-24 2014-01-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20.000 15.000 -57,14
2014-01-24 2014-01-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -20.000 310.000 -6,06 14,38 -287.600 4.457.800
2014-01-24 2014-01-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 20.000 330.000 6,45 0,60 12.000 198.000
2013-02-21 2013-02-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -25.000 35.000 -41,67
2013-02-21 2013-02-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -75.000 0 -100,00
2013-02-21 2013-02-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 25.000 310.000 8,77 0,60 15.000 186.000
2013-02-21 2013-02-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 75.000 285.000 35,71 0,60 45.000 171.000
2013-02-05 2013-02-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 110.000 110.000
2013-02-05 2013-02-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 90.000 90.000
2012-02-03 2012-02-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 110.000 110.000
2010-02-02 3 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
210.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)